CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer

Clinical trial NCT02052960 · COMPLETED

Trial details

NCT number: NCT02052960
Sponsor: Glycotope GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck

Start date: 2014-02-01
Primary completion: 2017-08-28
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.